What Autonomize AI does

Autonomize AI, founded in 2022 and headquartered in Austin, Texas, is a healthcare-native AI platform company that automates administrative and clinical workflows for large U.S. health plans, providers, pharmacy benefit managers (PBMs), and life sciences organizations. The company's flagship product, the Autonomize Intelligence Platform (Version 3 launched April 2026), is built on a proprietary Compound AI architecture that combines symbolic reasoning, retrieval-based grounding, and generative intelligence, organized around a living context graph of 10M+ clinical, regulatory, and coverage concepts. The platform includes four core modules: the Knowledge Center (curated knowledge graph), AI Studio (low-code agent builder), the Agent Marketplace (100+ pre-built, healthcare-native AI agents and Copilots covering prior authorization, care management, claims processing, appeals and grievances, payment integrity, risk adjustment, eligibility verification, and benefit orchestration), and the Command Center (observability and governance layer), supported by 50+ pre-built system connectors for EHRs, claims systems, FHIR APIs, and legacy inputs. Production deployments include 3 of the 5 largest U.S. health enterprises (a major national government plan, the largest PBM, and a large national commercial payer), plus named customers Molina Healthcare, Elevance Health, and Altais Health Solutions.

Autonomize monetizes primarily through multi-year enterprise SaaS subscriptions, with reported ARR growth of nearly 3x year over year in 2025. The company supplements direct enterprise sales with a professional services / forward-deployed engineering model in which solutions teams co-design and deploy workflows alongside customer clinical and operational staff, and layers in distribution through the Microsoft for Startups Pegasus Program and ServiceNow Build Partner channel (including Microsoft Marketplace listing). Contract value is not publicly disclosed, but customer-reported outcomes (up to 80% faster case review, 36,000 clinical hours saved per month, 3-5x ROI within 6-12 months) and the scale of anchor logos imply seven-figure-plus enterprise contracts at top accounts.

The company is venture-backed, having raised $4M in seed funding in 2023 and $28M in Series A funding in June 2025 (total $32M raised to date) from Valtruis, The Cigna Group Ventures, Tau Ventures, Asset Management Ventures, ATX Venture Partners, and Capital Factory. It maintains a leadership team that combines clinicians, former executives from Dell, Google, AWS, PwC, and UnitedHealthcare, and a healthcare-AI advisory board including Dr. Brian Anderson of CHAI, Bill Fandrich, and Keith Reynolds of Welldoc. The company employs 11-50 staff across the U.S., Canada, and India, and was named a 2026 World Economic Forum Technology Pioneer and a CB Insights Digital Health 50 company (2025).

Name

Autonomize AI

Legal name

Autonomize, Inc.

Website

https://autonomize.ai

Company type

Private

Founded year

2022

Operating status

Operating

Headcount range

101–250 employees

Short description

Autonomize AI offers a healthcare-native AI orchestration platform for U.S. health plans, providers, and PBMs. Its Compound AI architecture powers 100+ pre-built agents across prior authorization, care management, and claims, deployed at three of the five largest U.S. health enterprises.

Ownership category

akta.pro rank

Product category

Healthcare AI Software

NAICS

Custom Computer Programming Services (541511), Software Publishers (5132)

SIC

Services-Prepackaged Software (7372)

akta.pro primary industry

Agents & Autonomous Workflows (Tool Use, Planning, Multi-Agent) (HDAAACAF)

akta.pro secondary industry

Responsible AI, Security & Privacy Platforms (Safety, Guardrails, PII) (HDAEANAG)

Keywords

• Healthcare AI platform
• Agentic AI orchestration
• Prior authorization automation
• Clinical workflow AI
• Healthcare knowledge graph

Headquarters

HQ city

Austin

HQ country

United States

HQ region

North America

Offices4 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Enterprise SaaS subscriptions (ARR): Recurring subscription / multi-year enterprise contracts sold to large healthcare payers, providers, PBMs, and life sciences organizations. ARR grew nearly 3x year over year in 2025; the company delivers tens of millions of dollars in savings to customers, indicating land-and-expand enterprise SaaS economics with platform-level (multi-workflow) attach.
2. Professional services / Forward-deployed engineering engagements: Co-design, deployment, and ongoing change-management work performed by Forward Deployed Engineers and solutions teams alongside customer clinical/operational/IT staff, embedded into customer workflows.
3. Marketplace / hyperscaler channel sales: Distribution of AI solutions via Microsoft Marketplace (and by extension through Microsoft enterprise co-sell) and through ServiceNow's Build Partner program, providing an additional sales channel layered on top of direct enterprise sales.

Go-to-market motion4 records

Distribution channels4 records

Marketing channels7 records

Core offering

Autonomize AI builds and sells the Autonomize Intelligence Platform, a healthcare-native agentic AI orchestration platform that automates complex administrative and clinical workflows for U.S. health plans, providers, PBMs, and life sciences organizations. The offering combines a 10M+ concept Knowledge Center, AI Studio low-code builder, 100+ pre-built AI agents in the Agent Marketplace, Command Center for governance, and 50+ pre-built system connectors that allow customers to deploy pre-trained Copilots for prior authorization, care management, appeals & grievances, claims, payment integrity, and other workflows in days.

Product overview

Autonomize AI offers a platform-plus-modules architecture centered on the Autonomize Intelligence Platform, the company's flagship AI-native operating system for healthcare. The core platform is built on a Compound AI architecture that combines symbolic reasoning, retrieval-based grounding, and generative intelligence, and is organized around four foundational modules: the Knowledge Center (a curated knowledge graph that grounds agent decisions), AI Studio (a low-code builder for configuring AI agents and GenAI workflows), the Agent Marketplace (a catalog of 100+ pre-built AI agents), and the Command Center (an observability and monitoring dashboard). On top of this platform, Autonomize ships a portfolio of pre-built AI-native applications — formerly called AI Copilots — that automate high-volume healthcare workflows, including the Medical Prior Authorization, Care Management, Appeals & Grievances, Pharmacy Prior Authorization, Letters & Correspondence, Payment Integrity, Claims Processing, Risk Adjustment, Eligibility Verification, Complex Document Processing, Intake/Extraction/Case Creation, Benefit Orchestration, and Intelligent Benefit Management Copilots. Earlier-generation offerings Autonomize Pixel and Autonomize Wizard were the company's initial generative AI products for healthcare data management. The platform integrates with EHRs, claims systems, FHIR APIs, hyperscalers (Google Cloud, Microsoft Azure), ServiceNow, and the Atropos Health Alexandria real-world evidence library via 50+ pre-built connectors and MCP-style adapters.

Differentiator

Problem solved

Functional benefit

Brands

• Autonomize Intelligence Platform: The company's AI operating layer / platform for healthcare, including Version 3 launched in April 2026, spanning Knowledge Center, AI Marketplace, AI Studio, and Command Center.
• Autonomize AI Studio
• Autonomize Agent Marketplace
• Autonomize AI Copilots

Products and services

• Autonomize Intelligence Platform
• Autonomize AI Studio
• Autonomize Agent Marketplace
• Medical Prior Authorization Copilot
• Care Management Copilot
• Appeals & Grievances Copilot
• Pharmacy Prior Authorization Copilot
• Letters & Correspondence Copilot
• Payment Integrity Copilot
• Claims Processing Copilot
• Risk Adjustment Copilot
• Eligibility Verification Copilot
• Complex Document Processing Copilot
• Intake, Extraction, and Case Creation Copilot
• Benefit Orchestration Copilot
• Intelligent Benefit Management Copilot

Quantifiable outcome

• Up to 55% faster clinical reviews
• +14 more outcomes

Named customers10 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability10 records

Feature6 records

Partnerships

Six partnerships are on record, tiered core integration partner, flagship strategic partner, flagship ecosystem partner, core ecosystem partner and flagship customer and deployment partner.

• Atropos Healthcore integration partnerTechnology or Integration · 21 April 2026Workflow integration partner for Atropos Health's Alexandria evidence library. Autonomize AI is one of the strategic and workflow integration partners (alongside Meta, Microsoft, Heidi Health, Vim, Avo, Vye Health, Humata, and Arcadia) helping deploy Alexandria into clinical workflows reaching approximately one-third of U.S. physicians and half of major U.S. health systems.
• ServiceNowflagship strategic partnerStrategic or Co-development Partner · 5 March 2026Public ServiceNow Build Partner announced March 2026; co-building AI-driven healthcare solutions for payers, focusing on claims processing, fraud detection, care management, and utilization management. Combines Autonomize's agentic AI orchestration with ServiceNow's enterprise workflow platform; Autonomize is also referenced as a ServiceNow integration partner for healthcare workflows.
• Microsoft (Microsoft for Startups Pegasus Program)flagship ecosystem partnerStrategic or Co-development Partner · 5 November 2025Selected into the invite-only Microsoft for Startups Pegasus Program for high-potential venture-backed B2B startups. Unlocks enterprise co-sell, Marketplace listing, and 24-month go-to-market support; Autonomize plans to expand AI solutions via Microsoft Marketplace and collaborate with Microsoft enterprise teams.
• NVIDIA (NVIDIA Inception Program)core ecosystem partnerTechnology or Integration · 5 November 2025Member of NVIDIA's global AI startup accelerator, providing access to NVIDIA's technology stack, compute resources, and enterprise network for healthcare AI companies.
• Altais Health Solutionsflagship customer and deployment partnerStrategic or Co-development Partner · 20 May 2025Strategic partnership announced May 2025 to deploy Autonomize AI Copilots across Altais' care management and clinical quality operations. The deployment yielded a published case study showing 45% faster prior-authorization case review, 63% faster turnaround time, 50% productivity lift, and 54% fewer manual errors.
• Altais Health Solutionsflagship customer and deployment partnerImplementation/ SI/ Consulting Partner · 20 May 2025Note: Altais is both a strategic customer and a deployment partner; the partnership agreement embeds Autonomize AI Copilots across Altais' physician network of 10,000+ MDs and advanced-practice clinicians serving 500,000+ patients in California and beyond.

Scale indicators14 records

Recent moves7 records

Expansion highlights7 records

Direct peers

• Cohere Health: Cohere Health sells an AI-driven prior authorization and utilization management platform to U.S. health plans, overlapping directly with Autonomize's Medical PA and Utilization Management Copilots in the same payer customer segment.
• Anterior: Anterior offers an agentic AI platform for clinical prior authorization and medical necessity review, competing head-to-head with Autonomize's PA Copilot for health plan and provider customers.
• Humata Health: Humata Health builds AI agents that automate prior authorization and clinical documentation for payers and providers, directly comparable to Autonomize's PA and complex document processing agents.
• Infinx: Infinx provides AI-powered prior authorization, eligibility verification, and billing solutions for healthcare providers and payers, overlapping with Autonomize's Eligibility, PA, and Claims Copilots.
• Notable: Notable (now part of Commure) deploys AI agents for healthcare administrative workflows including PA, intake, and appeals — directly comparable to Autonomize's Agent Marketplace approach for payers and providers.
• Surescripts: Surescripts operates the largest U.S. pharmacy and clinical information network, with growing AI capabilities for pharmacy prior authorization that compete with Autonomize's Pharmacy PA Copilot in the PBM segment.
• Olive AI: Olive AI was a healthcare-specific AI automation platform targeting hospital and payer administrative workflows (including prior auth and claims); although it wound down operations, it is the closest historical analog to Autonomize's healthcare-native AI agent model.

Broad incumbents

• LeanTaas: LeanTaas applies AI/optimization to health system operations, including staffing, capacity, and patient flow — broader than Autonomize's payer focus but a comparable AI-for-healthcare-operations incumbent.
• Health Catalyst: Health Catalyst is an established healthcare data and analytics platform adding AI workflow capabilities; it overlaps with Autonomize's analytics, risk adjustment, and care management use cases for health systems and payers.
• Waystar: Waystar provides AI-enabled revenue cycle, claims, and prior authorization automation for U.S. providers and payers, competing with Autonomize's Claims Processing, Payment Integrity, and Eligibility Copilots as a broader incumbent.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/autonomizeai
• LinkedInlinkedin.com/company/autonomizeai

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Funding overview

Funding rounds2 records

Investors8 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Autonomize AI